293 related articles for article (PubMed ID: 12396907)
1. Anthrax bioterrorism: lessons learned and future directions.
Hughes JM; Gerberding JL
Emerg Infect Dis; 2002 Oct; 8(10):1013-4. PubMed ID: 12396907
[No Abstract] [Full Text] [Related]
2. Call-tracking data and the public health response to bioterrorism-related anthrax.
Mott JA; Treadwell TA; Hennessy TW; Rosenberg PA; Wolfe MI; Brown CM; Butler JC
Emerg Infect Dis; 2002 Oct; 8(10):1088-92. PubMed ID: 12396921
[TBL] [Abstract][Full Text] [Related]
3. Public health in the time of bioterrorism.
Perkins BA; Popovic T; Yeskey K
Emerg Infect Dis; 2002 Oct; 8(10):1015-8. PubMed ID: 12396908
[No Abstract] [Full Text] [Related]
4. Our first line of defense against bioterrorism part 2.
Simpson RL
Nurs Manage; 2002 May; 33(5):10, 11. PubMed ID: 12006878
[TBL] [Abstract][Full Text] [Related]
5. Responding to bioterrorism.
Breithaupt H
EMBO Rep; 2001 Dec; 2(12):1053. PubMed ID: 11743010
[No Abstract] [Full Text] [Related]
6. Lessons learned from the CDC's post-exposure prophylaxis program following the anthrax attacks of 2001.
Bresnitz EA
Pharmacoepidemiol Drug Saf; 2005 Jun; 14(6):389-91. PubMed ID: 15924332
[No Abstract] [Full Text] [Related]
7. US expands anti-bioterrorist measures.
Fox JL
Nat Biotechnol; 2001 Nov; 19(11):998-1000. PubMed ID: 11689831
[No Abstract] [Full Text] [Related]
8. Bioterrorism-related anthrax: international response by the Centers for Disease Control and Prevention.
Polyak CS; Macy JT; Irizarry-De La Cruz M; Lai JE; McAuliffe JF; Popovic T; Pillai SP; Mintz ED;
Emerg Infect Dis; 2002 Oct; 8(10):1056-9. PubMed ID: 12396915
[TBL] [Abstract][Full Text] [Related]
9. Ethics and bioterrorism research.
Bull Med Ethics; 2004 May; (198):13-20. PubMed ID: 15832477
[No Abstract] [Full Text] [Related]
10. Rethink anti-bioterrorism plans.
Nature; 2002 Jun; 417(6891):773. PubMed ID: 12075302
[No Abstract] [Full Text] [Related]
11. Communication lessons learned in the Emergency Operations Center during CDC's anthrax response: a commentary.
Vanderford ML
J Health Commun; 2003; 8 Suppl 1():11-2. PubMed ID: 14692567
[No Abstract] [Full Text] [Related]
12. Bioterrorism preparedness expenditures may compromise public health.
Dowling KC; Lipton RI
Am J Public Health; 2005 Oct; 95(10):1672; author reply 1672-3. PubMed ID: 16131631
[No Abstract] [Full Text] [Related]
13. Update: Investigation of bioterrorism-related anthrax, 2001.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(45):1008-10. PubMed ID: 11724158
[TBL] [Abstract][Full Text] [Related]
14. Order out of chaos: the self-organization of communication following the anthrax attacks.
Freimuth VS
Health Commun; 2006; 20(2):141-8. PubMed ID: 16965251
[TBL] [Abstract][Full Text] [Related]
15. Bioterrorism watch. Building a bridge over the abyss: will bioterrorism help bring disjointed health system together?
Evans G
Hosp Peer Rev; 2002 Apr; 27(4):suppl 1-2. PubMed ID: 11951727
[No Abstract] [Full Text] [Related]
16. A dose of reality for the health watchdogs.
Kluger J
Time; 2001 Oct; 158(19):65-6. PubMed ID: 11699134
[No Abstract] [Full Text] [Related]
17. Science and the fight against bioterrorism.
Rieff HI
FASEB J; 2002 Jan; 16(1):1. PubMed ID: 11772930
[No Abstract] [Full Text] [Related]
18. 'I need scientists!'.
Fineman H
Newsweek; 2001 Nov; 139(19):42-4. PubMed ID: 11710160
[No Abstract] [Full Text] [Related]
19. Booming biosafety labs probed.
Wadman M
Nature; 2009 Oct; 461(7264):577. PubMed ID: 19794463
[No Abstract] [Full Text] [Related]
20. Serious adverse events among participants in the Centers for Disease Control and Prevention's Anthrax Vaccine and Antimicrobial Availability Program for persons at risk for bioterrorism-related inhalational anthrax.
Tierney BC; Martin SW; Franzke LH; Marano N; Reissman DB; Louchart RD; Goff JA; Rosenstein NE; Sever JL; McNeil MM;
Clin Infect Dis; 2003 Oct; 37(7):905-11. PubMed ID: 13130401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
